Two Sigma Securities, LLC Cti Biopharma Corp Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.45 - $6.17 $243,023 - $336,956	54,612 New	54,612 $328,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $65,575 - $115,819	-18,472 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $35,096 - $96,608	18,472 New	18,472 $86,000
Q4 2020 Feb 16, 2021	SELL	$2.48 - $3.8 $57,655 - $88,342	-23,248 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.02 - $2.15 $23,712 - $49,983	23,248 New	23,248 $50,000
Q2 2019 Aug 14, 2019	SELL	$0.8 - $1.03 $9,672 - $12,453	-12,091 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.9 - $1.37 $10,881 - $16,564	12,091 New	12,091 $12,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.